Clinical Evaluation of Occlusal Stabilization Splints Fabricated Using Conventional Versus Fully Digital Workflow
Launched by CAIRO UNIVERSITY · Jul 10, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to make special mouth devices called occlusal splints, which are used to help people with temporomandibular joint disorders (TMD). TMD causes pain and problems with jaw movement, and these splints can ease discomfort and improve jaw function. Traditionally, making these splints involves a complicated and time-consuming process that requires many adjustments. This study will compare the traditional method to a newer, fully digital approach that uses advanced technology to create the splints more quickly and accurately.
People who may join this study are adults between 20 and 40 years old who have a full set of teeth and stable bite, and who experience symptoms like jaw or muscle pain, tenderness, headaches, or earaches related to TMD. Those with severe jaw movement problems, mental health issues, ongoing orthodontic treatment, recent injuries, or other dental problems won’t be eligible. Participants can expect to receive an occlusal splint made by either the traditional or digital method and will be part of a study that aims to find out which way works better and is easier for patients. This research could help improve treatment options for people with TMD in the future.
Gender
ALL
Eligibility criteria
- Inclusion criteria for participants:
- • Age 20-40 years old.
- • Complete dentition
- • Intact and stable occlusion.
- • TMD patients with more than one of following symptoms or signs: myofascial pain and /or pain in the TMJ, myofascial pain and/or pain in the TMJ on palpation, muscles tenderness, headache or earache
- Exclusion criteria for participants:
- • Patients with severe jaw functional limitations (jaw opening less than 3 fingers).
- • Patients suffering from depression, anxiety or mental disorder.
- • Patients with ongoing orthodontic treatments.
- • History of a recent trauma to face, head or neck.
- • Presence of dento-alveolar pathology.
- • Presence of sever or moderate periodontitis.
- • Patients with ongoing treatment related to TMD.
- Exclusion Criteria:
- • -
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported